Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands
- PMID: 16454543
- DOI: 10.2165/00002018-200629020-00006
Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands
Abstract
Background: The incidence of adverse drug reaction (ADR)-related hospitalisations has usually been assessed within hospitals. Because of the variability in results and methodology, it is difficult to extrapolate these results to a national level.
Objectives: To evaluate the incidence and characteristics of ADR-related hospitalisations in The Netherlands in 2001.
Methods: We conducted a nationwide study of all hospital admissions in 2001. Data were retrieved from a nationwide computer database for hospital discharge records. All acute, non-planned admissions to all Dutch academic and general hospitals in 2001 were included in the study (n = 668 714). From these admissions we selected all hospitalisations that were coded as drug-related, but intended forms of overdose, errors in administration and therapeutic failures were excluded. Hence, we extracted all ADR-related hospitalisations. We compared age, sex and the risk of a fatal outcome between patients admitted with ADRs and patients admitted for other reasons, as well as the most frequent main diagnoses in ADR-related hospitalisations and which drugs most frequently caused the ADRs. In addition, we evaluated to what extent these ADRs were reported to the Netherlands Pharmacovigilance Centre Lareb for spontaneous ADR reporting.
Results: In 2001, 12 249 hospitalisations were coded as ADR related. This was 1.83% of all acute hospital admissions in The Netherlands (95% CI 1.80, 1.86). The proportion increased with age from 0.8% (95% CI 0.75, 0.85) in the <18 years group to 3.2% in the >/=80 years group (95% CI 3.08, 3.32). The most frequent ADR-related diagnoses of hospitalisations were bleeding (n = 1048), non-specified 'unintended effect of drug' (n = 438), hypoglycaemia (n = 375) and fever (n = 347). The drugs most commonly associated with ADR-related hospitalisations were anticoagulants (n = 2185), cytostatics and immunosuppressives (n = 1809) and diuretics (n = 979). Six percent of the ADR-related hospitalisations had a fatal outcome (n = 734). Older age and female gender were associated with ADR-related hospitalisations. Only approximately 1% of the coded ADRs causing hospitalisation were reported to our national centre for spontaneous ADR reporting.
Conclusion: The proportion of ADR-related hospitalisations is substantial, especially considering the fact that not all ADRs may be recognised or mentioned in discharge letters. Under-reporting of ADRs that result in hospital admission to our national centre for spontaneous ADR reporting was considerable.
Similar articles
-
Adverse drug reaction-related hospitalisations: a population-based cohort study.Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):365-71. doi: 10.1002/pds.1565. Pharmacoepidemiol Drug Saf. 2008. PMID: 18302300
-
Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.PLoS One. 2017 Oct 16;12(10):e0186631. doi: 10.1371/journal.pone.0186631. eCollection 2017. PLoS One. 2017. PMID: 29036230 Free PMC article.
-
Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates.Int J Clin Pharm. 2015 Feb;37(1):105-12. doi: 10.1007/s11096-014-0046-3. Epub 2014 Dec 9. Int J Clin Pharm. 2015. PMID: 25488317
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Drug-related hospital admissions.Ann Pharmacother. 1993 Jul-Aug;27(7-8):832-40. doi: 10.1177/106002809302700702. Ann Pharmacother. 1993. PMID: 8364259 Review.
Cited by
-
The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.Drug Saf. 2010 Mar 1;33(3):233-44. doi: 10.2165/11319030-000000000-00000. Drug Saf. 2010. PMID: 20158287
-
Improvement in the handling of drug-drug interactions.Eur J Clin Pharmacol. 2008 Feb;64(2):167-71. doi: 10.1007/s00228-007-0436-8. Epub 2008 Jan 3. Eur J Clin Pharmacol. 2008. PMID: 18172623
-
Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German database.Eur J Clin Pharmacol. 2011 Sep;67(9):941-51. doi: 10.1007/s00228-011-1031-6. Epub 2011 Mar 31. Eur J Clin Pharmacol. 2011. PMID: 21452031
-
Pharmacogenetic characteristics of patients with complicated phenprocoumon dosing.Eur J Clin Pharmacol. 2009 Aug;65(8):783-8. doi: 10.1007/s00228-009-0639-2. Epub 2009 Mar 25. Eur J Clin Pharmacol. 2009. PMID: 19319511
-
Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.Drugs Aging. 2008;25(4):343-55. doi: 10.2165/00002512-200825040-00007. Drugs Aging. 2008. PMID: 18361544
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials